Previous 10 | Next 10 |
New York, New York--(Newsfile Corp. - June 21, 2022) - Levi & Korsinsky, LLP notifies investors in Verrica Pharmaceuticals, Inc. ("Verrica" or the "Company") (NASDAQ: VRCA) of a class action securities lawsuit. The lawsuit on behalf of Verrica investors has been commenced in the the Uni...
NEW YORK, June 02, 2022 (GLOBE NEWSWIRE) -- The law firm of Kirby McInerney LLP is investigating potential claims against Verrica Pharmaceuticals Inc. (“Verrica” or the “Company”) (NASDAQ: VRCA ). The investigation concerns whether Verrica has violate...
The law firm of Kirby McInerney LLP is investigating potential claims against Verrica Pharmaceuticals Inc. (“Verrica” or the “Company”) (NASDAQ: VRCA ). The investigation concerns whether Verrica has violated the federal securities laws and/or engaged...
I made a mistake, this was VRCA's third FDA rejection. VRCA has been pointing fingers instead of executing. VRCA press releases cross the line. Enough is enough! For further details see: I Would Avoid Verrica Pharmaceuticals Until CEO Change
The release of minutes from the Federal Reserve's latest meeting gave a late-day lift to Wall Street, helping the major averages post solid gains on Wednesday. The Nasdaq led the advance, climbing by 1.5%. A rebound in the retail sector contributed to the gains. This came amid ongoing reports...
=Gainers: BlackSky Technology (BKSY) +93%. StoneMor (STON) +51%. Genocea Biosciences (GNCA) +35%. Hoegh LNG Partners (HMLP) +31%. Caleres (CAL) +27%. Evelo Biosciences (EVLO) +20%. Spire Global (SPIR) +17%. Groupon (GRPN) +17%. Abercrombie & Fitch (ANF) +17%. Losers: Verrica Pharmaceutica...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Express released its first-quarter earnings report today. The company’s earnings beat estimates. It also put out a strong guidance despite inflation. Source: Helen89 / Shutterstock.com Express (NYSE...
Gainers: Elevation Oncology (ELEV) +20%. Cue Biopharma (CUE) +14%. Evelo Biosciences (EVLO) +13%. GeoVax Labs (GOVX) +13%. Immix Biopharma (IMMX) +9%. Losers: Verrica Pharmaceuticals (VRCA) -58%. PMV Pharmaceuticals (PMVP) -10%. TransMedics (TMDX) ...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Dick’s Sporting Goods stock is falling after releasing Q1 earnings. The company lowered its 2022 outlook in the report. However, it beat estimates for the current quarter. Source: George Sheldon via ...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Verrica Pharmaceuticals (NASDAQ: VRCA ) stock is sinking over 50% in morning trading The FDA declined to approve its treatment for “a viral skin disease” According to Verrica, the agency declined to...
News, Short Squeeze, Breakout and More Instantly...
Verrica Pharmaceuticals Inc. Company Name:
VRCA Stock Symbol:
NASDAQ Market:
Verrica Pharmaceuticals Inc. Website:
- Dormer Labs has discontinued the sale of all cantharidin-containing products into the United States - YCANTH is the only commercially available, FDA approved therapy for molluscum contagiosum and is clinically proven to be safe and effective WEST CHESTER, Pa., July 01, 202...
WEST CHESTER, Pa., May 30, 2024 (GLOBE NEWSWIRE) -- Verrica Pharmaceuticals Inc. (“Verrica” or “the Company”) (Nasdaq: VRCA), a dermatology therapeutics company developing medications for skin diseases requiring medical interventions, today announced that Ted White, Pr...
Global pivotal Phase 3 clinical trial would be conducted jointly by Verrica and Torii Pharmaceutical; trial expected to begin in the 1 st half of 2025 Amendment should benefit both parties from a cost and time to market standpoint; funding structure is expected to have a min...